JP2020517698A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517698A5 JP2020517698A5 JP2019558390A JP2019558390A JP2020517698A5 JP 2020517698 A5 JP2020517698 A5 JP 2020517698A5 JP 2019558390 A JP2019558390 A JP 2019558390A JP 2019558390 A JP2019558390 A JP 2019558390A JP 2020517698 A5 JP2020517698 A5 JP 2020517698A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrido
- pyrimidin
- amine
- pyridine
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc1cc*(Cc2c(C)ncnc2)cc1 Chemical compound Cc1cc*(Cc2c(C)ncnc2)cc1 0.000 description 3
- RIKMMFOAQPJVMX-UHFFFAOYSA-O Cc1c[nH][nH+]c1 Chemical compound Cc1c[nH][nH+]c1 RIKMMFOAQPJVMX-UHFFFAOYSA-O 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022144957A JP2022188056A (ja) | 2017-04-28 | 2022-09-13 | ６－６縮合二環式ヘテロアリール化合物及びｌａｔｓ阻害剤としてのその使用 |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762491526P | 2017-04-28 | 2017-04-28 | |
| US201762491475P | 2017-04-28 | 2017-04-28 | |
| US201762491484P | 2017-04-28 | 2017-04-28 | |
| US201762491573P | 2017-04-28 | 2017-04-28 | |
| US62/491,526 | 2017-04-28 | ||
| US62/491,573 | 2017-04-28 | ||
| US62/491,484 | 2017-04-28 | ||
| US62/491,475 | 2017-04-28 | ||
| US201862650232P | 2018-03-29 | 2018-03-29 | |
| US62/650,232 | 2018-03-29 | ||
| PCT/IB2018/052919 WO2018198077A2 (en) | 2017-04-28 | 2018-04-26 | 6-6 fused bicyclic heteroaryl compounds and their use as lats inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022144957A Division JP2022188056A (ja) | 2017-04-28 | 2022-09-13 | ６－６縮合二環式ヘテロアリール化合物及びｌａｔｓ阻害剤としてのその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020517698A JP2020517698A (ja) | 2020-06-18 |
| JP2020517698A5 true JP2020517698A5 (cg-RX-API-DMAC10.html) | 2021-06-10 |
| JP7247102B2 JP7247102B2 (ja) | 2023-03-28 |
Family
ID=62148436
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019558390A Active JP7247102B2 (ja) | 2017-04-28 | 2018-04-26 | ６－６縮合二環式ヘテロアリール化合物及びｌａｔｓ阻害剤としてのその使用 |
| JP2022144957A Pending JP2022188056A (ja) | 2017-04-28 | 2022-09-13 | ６－６縮合二環式ヘテロアリール化合物及びｌａｔｓ阻害剤としてのその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022144957A Pending JP2022188056A (ja) | 2017-04-28 | 2022-09-13 | ６－６縮合二環式ヘテロアリール化合物及びｌａｔｓ阻害剤としてのその使用 |
Country Status (25)
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017093969A1 (en) | 2015-12-04 | 2017-06-08 | Novartis Ag | Compositions and methods for immunooncology |
| WO2017139318A1 (en) | 2016-02-08 | 2017-08-17 | The Brigham And Women's Hospital, Inc. | Bioadhesive for corneal repair |
| TWI828027B (zh) | 2016-03-28 | 2024-01-01 | 美商英塞特公司 | 作為tam抑制劑之吡咯并三嗪化合物 |
| KR20190130608A (ko) | 2017-03-22 | 2019-11-22 | 노파르티스 아게 | 면역종양학을 위한 조성물 및 방법 |
| JOP20190257A1 (ar) | 2017-04-28 | 2019-10-28 | Novartis Ag | مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats |
| US10633387B2 (en) | 2017-09-27 | 2020-04-28 | Incyte Corporation | Salts of TAM inhibitors |
| US20210253518A1 (en) | 2018-06-08 | 2021-08-19 | Nissan Chemical Corporation | Kinase inhibitor |
| ES3031110T3 (en) | 2018-06-29 | 2025-07-04 | Incyte Corp | Formulations of an axl/mer inhibitor |
| WO2020081673A1 (en) * | 2018-10-16 | 2020-04-23 | The Schepens Eye Research Institute, Inc. | Bioadhesive for soft tissue repair |
| UY38427A (es) * | 2018-10-26 | 2020-05-29 | Novartis Ag | Métodos y composiciones para terapia con células oculares |
| WO2020122104A1 (ja) * | 2018-12-11 | 2020-06-18 | 国立大学法人京都大学 | ゲノムｄｎａに欠失を誘導する方法 |
| EP3915636A4 (en) | 2019-01-30 | 2022-03-09 | Nissan Chemical Corporation | HYDRAZIDE COMPOUND AND KINASE INHIBITOR |
| CN112707905B (zh) * | 2019-10-25 | 2024-07-02 | 武汉誉祥医药科技有限公司 | 一种三并杂环化合物及其制备方法和用途 |
| GB201915831D0 (en) * | 2019-10-31 | 2019-12-18 | Cancer Research Tech Ltd | Compounds, compositions and therapeutic uses thereof |
| GB201915829D0 (en) * | 2019-10-31 | 2019-12-18 | Cancer Research Tech Ltd | Compounds, compositions and therapeutic uses thereof |
| EP4065230A1 (en) * | 2019-11-27 | 2022-10-05 | Genentech, Inc. | Therapeutic compounds |
| CN115515579B (zh) * | 2020-02-05 | 2025-09-30 | 洛克菲勒大学 | 吡咯并[2,3-b]吡啶-3-甲酰胺组合物和改善听力损失的方法 |
| PH12022552347A1 (en) | 2020-03-06 | 2024-01-29 | Incyte Corp | Combination therapy comprising axl/mer and pd-1/pd-l1 inhibitors |
| CN111443068B (zh) * | 2020-03-06 | 2023-06-27 | 天津大学 | 具有多重刺激响应特性的纯有机室温磷光材料及筛选方法和应用 |
| US20230348852A1 (en) | 2020-04-27 | 2023-11-02 | Novartis Ag | Methods and compositions for ocular cell therapy |
| US11746100B2 (en) * | 2020-04-28 | 2023-09-05 | Global Blood Therapeutics, Inc. | Cycloalkyl pyrimidines as ferroportin inhibitors |
| CN112305126A (zh) * | 2020-11-02 | 2021-02-02 | 宁夏贝利特生物科技有限公司 | 一种硝酸胍含量的测定方法 |
| AR126078A1 (es) * | 2021-06-04 | 2023-09-06 | Genentech Inc | Compuestos de 2,8-diazaspiro[4.5]decano |
| US20240309195A1 (en) * | 2021-08-23 | 2024-09-19 | Emd Millipore Corporation | System And Method For Photopolymerizing Electrophoretic Gels |
| CN115974868B (zh) * | 2022-11-07 | 2024-04-12 | 安徽理工大学 | 一种尿嘧啶衍生物的合成方法及其抗肺纤维化方面的潜在应用 |
| EP4687896A1 (en) * | 2023-04-04 | 2026-02-11 | Children's Hospital Los Angeles | Lats kinase inhibitor to treat retinal degeneration |
| CN119462609B (zh) * | 2024-10-25 | 2025-12-26 | 烟台皓元生物医药科技有限公司 | 一种lats抑制剂vt02956的制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004065392A1 (en) | 2003-01-24 | 2004-08-05 | Smithkline Beecham Corporation | Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands |
| MX2007010401A (es) | 2005-02-25 | 2008-02-19 | Kudos Pharm Ltd | Derivados de 2,4-diamino-piridopirimidina y su uso como inhbidores de mtor. |
| AU2008235455A1 (en) | 2007-04-06 | 2008-10-16 | Novartis Ag | 2, 6-naphthyridine derivatives as protein kinase modulators |
| US8163763B2 (en) | 2008-07-31 | 2012-04-24 | Genentech, Inc. | Pyrimidine compounds, compositions and methods of use |
| US20110319409A1 (en) * | 2010-06-23 | 2011-12-29 | Cox Christopher D | 7-aza-quinazoline pde10 inhibitors |
| JP5761827B2 (ja) | 2011-07-15 | 2015-08-12 | 国立大学法人大阪大学 | 角膜内皮細胞の調製方法 |
| EP2760857A1 (en) | 2011-09-27 | 2014-08-06 | F.Hoffmann-La Roche Ag | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| JP6535430B2 (ja) * | 2012-09-28 | 2019-06-26 | イグニタ、インク． | 非定型プロテインキナーゼｃのアザキナゾリン阻害薬 |
| CN111206032B (zh) * | 2013-12-12 | 2024-07-19 | 布罗德研究所有限公司 | 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用 |
| TWI675836B (zh) * | 2014-03-25 | 2019-11-01 | 美商伊格尼塔公司 | 非典型蛋白質激酶ｃ之氮雜喹唑啉抑制劑 |
| WO2016046768A1 (en) | 2014-09-24 | 2016-03-31 | Friedrich Miescher Institute For Biomedical Research | Lats and breast cancer |
| CN108137547B (zh) | 2015-08-03 | 2021-11-12 | 百时美施贵宝公司 | 可用作TNFα调节剂的杂环化合物 |
| WO2017035116A1 (en) | 2015-08-25 | 2017-03-02 | President And Fellows Of Harvard College | Methods and compositions relating to the diagnosis and treatment of cancer |
| JOP20190257A1 (ar) | 2017-04-28 | 2019-10-28 | Novartis Ag | مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats |
| UY38427A (es) * | 2018-10-26 | 2020-05-29 | Novartis Ag | Métodos y composiciones para terapia con células oculares |
-
2017
- 2017-06-16 JO JOP/2019/0257A patent/JOP20190257A1/ar unknown
-
2018
- 2018-04-26 CU CU2020000080A patent/CU20200080A7/es unknown
- 2018-04-26 AU AU2018260495A patent/AU2018260495B2/en not_active Ceased
- 2018-04-26 JP JP2019558390A patent/JP7247102B2/ja active Active
- 2018-04-26 WO PCT/IB2018/052919 patent/WO2018198077A2/en not_active Ceased
- 2018-04-26 SG SG11201908615R patent/SG11201908615RA/en unknown
- 2018-04-26 CA CA3056906A patent/CA3056906A1/en active Pending
- 2018-04-26 US US15/963,816 patent/US11458138B2/en active Active
- 2018-04-26 CN CN202210409194.5A patent/CN114703144A/zh not_active Withdrawn
- 2018-04-26 PE PE2019002107A patent/PE20200292A1/es unknown
- 2018-04-26 BR BR112019022512-9A patent/BR112019022512A2/pt not_active IP Right Cessation
- 2018-04-26 MA MA049285A patent/MA49285A/fr unknown
- 2018-04-26 UY UY0001037703A patent/UY37703A/es not_active Application Discontinuation
- 2018-04-26 KR KR1020197034688A patent/KR20190142776A/ko not_active Withdrawn
- 2018-04-26 ES ES18723981T patent/ES2983611T3/es active Active
- 2018-04-26 CR CR20190483A patent/CR20190483A/es unknown
- 2018-04-26 CN CN202210409770.6A patent/CN114621222B/zh active Active
- 2018-04-26 TW TW107114216A patent/TW201843140A/zh unknown
- 2018-04-26 EP EP18723981.9A patent/EP3615537B1/en active Active
- 2018-04-26 MX MX2019012756A patent/MX2019012756A/es unknown
- 2018-04-26 CU CU2019000086A patent/CU20190086A7/es unknown
- 2018-04-26 CN CN201880027586.7A patent/CN110573511B/zh active Active
-
2019
- 2019-09-11 IL IL269293A patent/IL269293B/en unknown
- 2019-10-24 DO DO2019000273A patent/DOP2019000273A/es unknown
- 2019-10-24 CL CL2019003049A patent/CL2019003049A1/es unknown
- 2019-10-25 EC ECSENADI201976732A patent/ECSP19076732A/es unknown
- 2019-10-25 CO CONC2019/0011873A patent/CO2019011873A2/es unknown
- 2019-10-28 PH PH12019502436A patent/PH12019502436A1/en unknown
-
2021
- 2021-12-14 AU AU2021286281A patent/AU2021286281A1/en not_active Abandoned
-
2022
- 2022-05-09 IL IL292857A patent/IL292857A/en unknown
- 2022-08-18 US US17/820,613 patent/US20230190751A1/en not_active Abandoned
- 2022-09-13 JP JP2022144957A patent/JP2022188056A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230190751A1 (en) | 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors | |
| KR102635333B1 (ko) | Pd-1/pd-l1 억제제 | |
| CN104136444B (zh) | Fgf受体(fgfr)激动剂二聚化合物、及其制备方法和治疗用途 | |
| JP2015518843A (ja) | 創傷、例えば、糖尿病性創傷の処置における、ｄｐｐ−４阻害剤と組み合わせてもよい生物活性物質としてのケラチン生成細胞の使用 | |
| ES2659980T3 (es) | Agente para promover la adherencia de células endoteliales de la córnea | |
| Parker et al. | Hydrogel for simultaneous tunable growth factor delivery and enhanced viability of encapsulated cells in vitro | |
| CA3116512A1 (en) | Methods and compositions for ocular cell therapy | |
| AU2018361971A1 (en) | Compounds and use thereof in the expansion of stem cells and/or progenitor cells | |
| CN110662752A (zh) | 用于临床管理由衰老细胞引起或介导的病症以及治疗癌症的Bcl家族拮抗剂磷杂环化合物 | |
| CA3154084A1 (en) | Feeder-based and feeder-free stem cell culture systems for stratified epithelial stem cells, and uses related thereto | |
| CN110402141A (zh) | Axl抑制剂和EGFR酪氨酸激酶抑制剂的联合疗法 | |
| RU2022117596A (ru) | 6-6-конденсированные бициклические гетероарильные соединения и их применение в качестве ингибиторов lats | |
| RU2775721C2 (ru) | 6-6-конденсированные бициклические гетероарильные соединения и их применение в качестве ингибиторов lats | |
| EA038453B1 (ru) | 6-6-конденсированные бициклические гетероарильные соединения и их применение в качестве ингибиторов lats | |
| US20250376466A1 (en) | Ester compounds and use thereof | |
| JP5922563B2 (ja) | 抗がん剤 | |
| HK40079589A (en) | Feeder-based and feeder-free stem cell culture systems for stratified epithelial stem cells, and uses related thereto | |
| HK40068336B (en) | Compounds for the treatment of kinase-dependent disorders |